Granules India — Latest News

Every announcement Granules India has filed with the exchanges that we have reported, newest first. Each story links the original filing.

NSE: GRANULES BSE: 532482 Pharmaceuticals & Biotechnology 2 stories

Price

₹857.5

Market Cap

₹21,248.58 Cr

Revenue TTM

₹5,632.31 Cr

P/E (TTM)

32.08×

Sector 50.35×

Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.

Promoter Buying · 1 Product Launched · 1
Promoter Buying

Granules India Promoter Uma Devi Chigurupati Acquires 2.48 Crore Shares via Open Market

Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India via the open market, raising her stake to 12.51%. Read more on this transa…

Product Launched

Granules India Secures Sole First-to-File Status for Sodium Oxybate Generic in US

Granules India secures Sole First-to-File ANDA status for Sodium Oxybate ER, the generic equivalent of LUMRYZ, targeting the US narcolepsy treatment …

Track Granules India in real time

ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Granules India files something material.

Start Free — 15-day trial